Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia


Ren, H., Elliott, N., Lye, B., Sharif Shohan, M. U., Cross, J. W., Field, L., Ponnusamy, K., Rice, S., Jackson, T., Leontari, I., El Ouazzani, N., Thomas, R., Inglott, S., Bartram, J., Smith, O., Bond, J., Roberts, I. A. G., Halsey, C., Bashford-Rogers, R., Milne, T.A., Roy, A., Karadimitris, A. (2026).